PL2575858T3 - Sposoby leczenia zespołu nerczycowego - Google Patents

Sposoby leczenia zespołu nerczycowego

Info

Publication number
PL2575858T3
PL2575858T3 PL11790534T PL11790534T PL2575858T3 PL 2575858 T3 PL2575858 T3 PL 2575858T3 PL 11790534 T PL11790534 T PL 11790534T PL 11790534 T PL11790534 T PL 11790534T PL 2575858 T3 PL2575858 T3 PL 2575858T3
Authority
PL
Poland
Prior art keywords
treatment
methods
related conditions
nephrotic syndrome
nephrotic
Prior art date
Application number
PL11790534T
Other languages
English (en)
Polish (pl)
Inventor
Sumant S. CHUGH
Original Assignee
Sumant S. CHUGH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumant S. CHUGH filed Critical Sumant S. CHUGH
Publication of PL2575858T3 publication Critical patent/PL2575858T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PL11790534T 2010-06-05 2011-06-06 Sposoby leczenia zespołu nerczycowego PL2575858T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US35186610P 2010-06-05 2010-06-05
PCT/US2011/039255 WO2011153525A2 (en) 2010-06-05 2011-06-06 Methods for treatment of nephrotic syndrome and related conditions
EP11790534.9A EP2575858B1 (en) 2010-06-05 2011-06-06 Methods for treatment of nephrotic syndrome and related conditions

Publications (1)

Publication Number Publication Date
PL2575858T3 true PL2575858T3 (pl) 2018-08-31

Family

ID=45067339

Family Applications (1)

Application Number Title Priority Date Filing Date
PL11790534T PL2575858T3 (pl) 2010-06-05 2011-06-06 Sposoby leczenia zespołu nerczycowego

Country Status (12)

Country Link
EP (2) EP2575858B1 (enExample)
JP (1) JP5904560B2 (enExample)
KR (1) KR20130132375A (enExample)
CN (2) CN103140234B (enExample)
AU (1) AU2011261196B2 (enExample)
CA (1) CA2801579C (enExample)
DK (1) DK2575858T3 (enExample)
ES (1) ES2663096T3 (enExample)
NO (1) NO2575858T3 (enExample)
PL (1) PL2575858T3 (enExample)
PT (1) PT2575858T (enExample)
WO (1) WO2011153525A2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110301103A1 (en) 2010-06-05 2011-12-08 Chugh Sumant S Methods of Treatment
US9139629B2 (en) 2010-06-05 2015-09-22 The Uab Research Foundation Methods for treatment of nephrotic syndrome and related conditions
JP2016516726A (ja) * 2013-03-15 2016-06-09 ザ・ユー・エイ・ビー・リサーチ・フアンデーシヨン ネフローゼ症候群及び関連状態の治療方法
WO2015107501A1 (en) * 2014-01-20 2015-07-23 Ghiggeri Gian Marco In vitro method for predicting, diagnosing and monitoring in therapeutic follow up lupus nephritis
CN114934021B (zh) * 2022-04-21 2023-08-08 复旦大学附属儿科医院 一种Angptl3敲除的鼠永生化足细胞系及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001005825A2 (en) * 1999-07-16 2001-01-25 Hyseq, Inc. Nucleic acid sequences encoding putative angiopoietin proteins
JP2005080508A (ja) * 2003-09-04 2005-03-31 Sankyo Co Ltd 脂質代謝改善剤の試験方法
CN1980686A (zh) * 2004-04-05 2007-06-13 安斯泰来制药有限公司 抗肥胖药
MX2007000783A (es) * 2004-07-20 2007-04-09 Genentech Inc Inhibidores de proteina angiopoietina tipo 4, combinaciones y su uso.
EP2007899B1 (en) * 2006-03-20 2017-06-07 Celldex Therapeutics, Inc. Antibodies directed to angiopoietin-like protein 4 and uses thereof
CA2903133C (en) * 2007-05-31 2021-10-19 Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services National Institutes Of Health N-acetyl mannosamine or derivatives thereof for use in treating a kidney disorder in a mammal

Also Published As

Publication number Publication date
JP5904560B2 (ja) 2016-04-13
CA2801579C (en) 2021-12-14
JP2013528625A (ja) 2013-07-11
CN103140234B (zh) 2016-12-21
ES2663096T3 (es) 2018-04-11
CA2801579A1 (en) 2011-12-08
HK1252916A1 (en) 2019-06-06
AU2011261196A1 (en) 2013-01-10
WO2011153525A2 (en) 2011-12-08
KR20130132375A (ko) 2013-12-04
EP3318269B1 (en) 2024-03-13
NO2575858T3 (enExample) 2018-05-19
EP2575858A4 (en) 2014-01-01
EP2575858A2 (en) 2013-04-10
CN103140234A (zh) 2013-06-05
AU2011261196B2 (en) 2015-05-21
EP3318269A1 (en) 2018-05-09
WO2011153525A9 (en) 2012-04-19
DK2575858T3 (en) 2018-03-12
EP3318269C0 (en) 2024-03-13
PT2575858T (pt) 2018-03-22
CN107412729A (zh) 2017-12-01
EP2575858B1 (en) 2017-12-20

Similar Documents

Publication Publication Date Title
EP2603202A4 (en) COMPOSITIONS AND METHOD FOR THE TREATMENT OF TAUOPATHIES
IL248530A0 (en) Biomarkers and treatment methods
ZA201304280B (en) Treatment of jak2-mediated conditions
EP2771030A4 (en) COMPOSITIONS AND METHOD FOR THE TREATMENT OF PROTEINOPATHIES
IL226352A0 (en) שקיטה@לטיפול@עם@מעקב@braf
EP2429584A4 (en) TREATMENT PROCEDURE AND COMPOSITIONS
GB201018147D0 (en) Method of treatment
GB201302653D0 (en) Pharmaceutical compositions and methods of treatment
EP2572730A4 (en) PROCESS FOR PROPHYLAXIS OR TREATMENT OF METABOLIC SYNDROME
SG2014014724A (en) METHODS FOR THE TREATMENT OF IL-1ß RELATED CONDITIONS
EP2574172A4 (en) MATERIALS AND METHOD FOR TREATING INFLAMMATION
ZA201207973B (en) Treatment of gout
EP2480579A4 (en) METHODS OF TREATING INFLAMMATION
IL225793A0 (en) Methods and preparations for curing insulin-related medical conditions
ZA201301936B (en) Methods and compositions for treatment of diabetes and dyslipidemia
IL256026B (en) Treatment methods
GB201003920D0 (en) Method of treatment
PT2575858T (pt) Métodos para o tratamento da síndrome nefrótica e condições relacionadas
ZA201305497B (en) Methods and compositions for preventing and treating osteoarthritis
ZA201207496B (en) Treatment of chicory
GB201018149D0 (en) Method of treatment
ZA201207497B (en) Treatment of chicory
EP2585103A4 (en) METHOD OF TREATMENT
GB201020015D0 (en) Method of treatment
WO2013006854A9 (en) Compositions and methods for treating enterobacteriaceae